(Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate Ph2PCH2CH2SPh-κP,κS Ligand

Gerd Ludwig,Ivan Ranđelović,Dušan Dimić,Teodora Komazec,Danijela Maksimović-Ivanić,Sanja Mijatović,Tobias Rüffer,Goran N. Kaluđerović

DOI: https://doi.org/10.3390/biom14040420

IF: 6.064

2024-03-31

Biomolecules

Abstract:The (pentamethylcyclopentadienyl)chloridoiridium(III) complex bearing a κP,κS-bonded Ph2PCH2CH2SPh ligand ([Ir(η5-C5Me5)Cl(Ph2P(CH2)2SPh-κP,κS)]PF6, (1)] was synthesized and characterized. Multinuclear (1H, 13C and 31P) NMR spectroscopy was employed for the determination of the structure. Moreover, SC-XRD confirmed the proposed structure belongs to the "piano stool" type. The Hirshfeld surface analysis outlined the most important intermolecular interactions in the structure. The crystallographic structure was optimized at the B3LYP-D3BJ/6-311++G(d,p)(H,C,P,S,Cl)/LanL2DZ(Ir) level of theory. The applicability of this level was verified through a comparison of experimental and theoretical bond lengths and angles, and 1H and 13C NMR chemical shifts. The Natural Bond Orbital theory was used to identify and quantify the intramolecular stabilization interactions, especially those between donor atoms and Ir(III) ions. Complex 1 was tested on antitumor activity against five human tumor cell lines: MCF-7 breast adenocarcinoma, SW480 colon adenocarcinoma, 518A2 melanoma, 8505C human thyroid carcinoma and A253 submandibular carcinoma. Complex 1 showed superior antitumor activity against cisplatin-resistant MCF-7, SW480 and 8505C cell lines. The mechanism of tumoricidal action on 8505C cells indicates the involvement of caspase-induced apoptosis, accompanied by a considerable reduction in ROS/RNS and proliferation potential of treated cells.

biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop new iridium(III) complexes as potential anticancer drugs, especially for cisplatin - resistant tumor cell lines. Specifically, the researchers synthesized a pentamethylcyclopentadienyliridium(III) chloride complex with a bidentate Ph_2PCH_2CH_2SPh - κP,κS ligand and carried out structural characterization and theoretical analysis on it. In addition, this study also evaluated the antitumor activity of this complex against a variety of human tumor cell lines in vitro (such as breast adenocarcinoma MCF - 7, colon adenocarcinoma SW480, melanoma 518A2, thyroid cancer 8505C and submandibular adenocarcinoma A253), and explored its killing mechanism against the 8505C cell line. Through this study, the authors hope to discover a new iridium(III) complex that can overcome cisplatin resistance, thereby providing a new strategy for the treatment of resistant tumors. The research results show that this complex exhibits excellent antitumor activity against several cisplatin - resistant cell lines, and its mechanism of action may involve reducing cell proliferation and oxidative stress levels through the induction of apoptosis.

(Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate Ph2PCH2CH2SPh-κP,κS Ligand

Synthesis and characterization of new iridium(III) complexes containing the fragment [Cp*IrCl2] and the ligands 2- and 4-aminobenzonitryl and 2- and 4-aminopyridine

Half-sandwich Iridium N-heterocyclic Carbene Anticancer Complexes

(1,2-Dicyanoethylenedithiolato-κ 2 S , S ′)(η 5 -pentamethylcyclopentadienyl)iridium(III)

Syntheses, Crystal Structures, and Photoluminescence of a Series of Iridium(III) Complexes Containing the Pentafluorosulfanyl Group

Rational Design and Synthesis of AIE Active Cationic Ir(III) Complexes Featuring Iminopyridine Ligand with Dibenzosuberane Core

Synthesis, Properties and Crystal Structure of an Octahedral Iridium(iii) Complex with an Arylnitrene Inserted into an Ir-C Bond

Synthesis, photophysical characterisation, quantum-chemical study and in vitro antiproliferative activity of cyclometalated Ir(III) complexes based on 3,5-dimethyl-1-phenyl-1 H-pyrazole and N,N-donor ligands

Synthesis and Structural Characterization of Macrocyclic Half-Sandwich Rhodium(III) and Iridium(III) Complexes Bearing Bipyridyl Derivatives and Terephthalate

Synthesis, Crystal Structure And Photoluminescence Properties Of An Organometallic Ir Complex Containing 2,2'-Bipyrimidine As Ancillary Ligand

Synthesis and Full Characterization of an Iridium B-H Activation Intermediate of the Monocarba-Closo-dodecaborate Anion.

Synthesis, Characterization, and Electrochemical Properties of Molecular Rectangles of Half-Sandwich Iridium Complexes Containing Bridging Chloranilate Ligands

Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes

Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity

Preparation and Bioactivity of Iridium(III) Phenanthroline Complexes with Halide Ions and Pyridine Leaving Groups

Synthesis and Characterization of IrH<sub>2</sub>{Si(OTf)Ph<sub>2</sub>}(TFB)(PR<sub>3</sub>) (PR<sub>3</sub>= P<sup>i</sup>Pr<sub>3</sub>, PCy<sub>3</sub>): First Base-Stabilized Silylene Complexes of Iridium

Iridium(III) Complexes Bearing a Formal Tetradentate Coordination Chelate: Structural Properties and Phosphorescence Fine-Tuned by Ancillaries

Synthesis, X-ray Studies and Photophysical Properties of Iridium(III) Complexes Incorporating Functionalized 2,2′:6′,2′′ Terpyridines and 2,6-Bis(thiazol-2-yl)pyridines

Synthesis, structure and optoelectronic properties of iridium(III) complexes bearing a four-membered Ir-N-C N chelate structure

Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells

Synthesis, Structure and Effects of an Azoimine Functionalized Iridium Complex on Cancer Cells